BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3110277)

  • 1. Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.
    Jung G; Martin DE; Müller-Eberhard HJ
    J Immunol; 1987 Jul; 139(2):639-44. PubMed ID: 3110277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clonal analysis of human peripheral blood lymphocytes displaying natural killer-like activity.
    Roberts K; Moore M
    Eur J Immunol; 1985 May; 15(5):448-56. PubMed ID: 3873338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human cytotoxic lymphocytes directed against cells infected with typhus group rickettsiae: evidence for lymphokine activation of effectors.
    Carl M; Dasch GA
    J Immunol; 1986 Apr; 136(7):2654-61. PubMed ID: 3081648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells.
    Weber WE; Buurman WA; Vandermeeren MM; Raus JC
    J Immunol; 1985 Oct; 135(4):2337-42. PubMed ID: 3875651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subsets differentially induce class II human leukocyte antigens on allogeneic microvascular endothelial cells.
    Pardi R; Bender JR; Engleman EG
    J Immunol; 1987 Oct; 139(8):2585-92. PubMed ID: 3116086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes.
    Schwarz RE; Hiserodt JC
    J Immunol; 1988 Nov; 141(10):3318-23. PubMed ID: 3263421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.
    Van Wauwe JP; Goossens JG; Beverley PC
    J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines.
    Lanier LL; Le AM; Ding A; Evans EL; Krensky AM; Clayberger C; Phillips JH
    J Immunol; 1987 Apr; 138(7):2019-23. PubMed ID: 2951430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine.
    Warren HS
    J Immunol; 1984 Jun; 132(6):2888-94. PubMed ID: 6233364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tac antigen-positive T cells activated in autologous mixed lymphocyte reaction regulate the generation of killer T cells against hapten-modified autologous cells.
    Kumagai S; Namiuchi S; Ozaki S; Sano H; Tsubata T; Suginoshita T; Imura H
    J Immunol; 1985 Feb; 134(2):711-7. PubMed ID: 2981269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS; Thiele DL; Lipsky PE
    J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
    Zhu HG; Klein-Franke A; Anderer FA
    Anticancer Res; 1994; 14(3A):953-61. PubMed ID: 8074498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM; Zhu HG; Anderer FA
    Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
    Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
    Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of antileukemia lytic activity by OKT3 monoclonal antibody: synergism of OKT3 and interleukin-2.
    Lotzová E; Savary CA; Herberman RB; McCredie KB; Keating MJ; Freireich EJ
    Nat Immun Cell Growth Regul; 1987; 6(5):219-23. PubMed ID: 3502169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
    Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
    J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
    Schmidt RE; Bartley G; Levine H; Schlossman SF; Ritz J
    J Immunol; 1985 Aug; 135(2):1020-5. PubMed ID: 3924996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
    Schwab R; Crow MK; Russo C; Weksler ME
    J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.